Tau Oligomers Neurotoxicity.

Area of Science:

• Neuroscience
• Cell Biology
• Biochemistry

Background:

• Tau protein is implicated in neurodegenerative diseases known as tauopathies.
• While insoluble tau aggregates (neurofibrillary tangles) are hallmarks, intermediate tau forms, specifically oligomers (TauOs), are increasingly recognized as key drivers of toxicity.
• Tauopathies, including Alzheimer's disease (AD), are characterized by neuronal dysfunction and loss, potentially influenced by interactions with other aggregated proteins like beta-amyloid and alpha-synuclein.

Purpose of the Study:

• To review the current literature on the mechanisms of tau oligomer (TauOs) neurotoxicity.
• To elucidate the damaging effects of TauOs on critical cellular processes.
• To highlight the role of TauOs in the pathogenesis of tauopathies.

Main Methods:

• Literature review of recent scientific publications.
• Analysis of studies investigating tau oligomer formation and toxicity.
• Synthesis of findings on cellular and molecular mechanisms of TauOs-induced damage.

Main Results:

• Tau oligomers (TauOs) are identified as the primary toxic species responsible for neuronal dysfunction and loss in tauopathies.
• TauOs exert damaging effects on genome stability, nuclear function, mitochondrial energy production, cell signaling, synaptic plasticity, microtubule assembly, axonal transport, and protein degradation systems.
• Interactions between tau oligomers and other pathological protein oligomers (e.g., beta-amyloid, alpha-synuclein) may exacerbate disease progression.

Conclusions:

• Tau oligomers are critical mediators of neurotoxicity in tauopathies.
• Understanding TauOs' detrimental effects on cellular functions is crucial for developing therapeutic strategies for Alzheimer's disease and other tauopathies.
• Further research into the interactions of different toxic oligomeric species is warranted.